More than 403,000 people are now diagnosed with cancer each year in the UK, a record figure that means a person receives the news every 80 seconds, according to a major new analysis.
The stark statistics, published by Cancer Research UK in its Cancer in the UK Report 2026, highlight a health system grappling with a relentless demographic shift. The primary driver is the nation’s growing and ageing population, as the risk of developing the disease increases significantly with age. Over half of all new cases are diagnosed in people aged 70 and over, with incidence rates highest among those aged 85 to 89.
Services under ‘immense strain’ as waiting times lag
The charity warns that this rising demand is placing immense strain on NHS cancer services, with waiting times across the UK among the worst on record. While death rates have fallen and long-term survival has improved—with 1 in 2 people now surviving a decade or more compared to 1 in 4 in the 1970s—this hard-won progress is at risk of stalling.
The pressure is visible in the performance data. In England, while the 28-day Faster Diagnosis Standard was met in February 2026, with 80.5% of people getting a diagnosis or all-clear within a month of an urgent referral, two other key targets were missed. Only 68.6% of patients started treatment within 62 days of referral, against a target of 85%, a standard not met since December 2015. A further 93% began treatment within 31 days of a decision to treat, below the 96% target.
The backlog of patients in England waiting over 62 days, which peaked at nearly 34,000 in 2022, had been reduced to just over 17,000 by late 2024. However, the scale of the challenge remains vast, with approximately 107,000 cancer patients across the UK waiting more than 62 days to start treatment in 2025. Cancer Research UK noted the situation is “much worse” in Northern Ireland, and in Scotland, performance for the 62-day standard fell to 68.9% in the first quarter of 2025, well below the 95% target.
Compounding the crisis are deep health inequalities. In England’s most deprived areas, cancer death rates are almost 60% higher than in the least deprived, equating to an estimated 28,400 preventable deaths annually linked to socioeconomic disadvantage.
A national plan and calls for urgent investment
In response, the Government published a 10-year National Cancer Plan for England in February 2026, which Cancer Research UK called a “crucial step”. The plan aims for the fastest improvement in cancer survival this century, with a goal that by 2035, 75% of people diagnosed will survive for five years or more or live well with cancer.
Its ambitions are supported by a £2.3 billion investment to deliver 9.5 million additional tests by 2029, including more scanners, and plans to increase robot-assisted procedures. It also commits to meeting all cancer waiting time standards by the end of the current Parliament in 2029. A Department of Health and Social Care spokesperson pointed to an extra £26 billion for the NHS and said the number of patients getting a timely cancer diagnosis or all-clear is the highest in five years.
However, Michelle Mitchell, Cancer Research UK’s chief executive, stressed that publication alone is not enough. “Publishing the plan is not a ‘job done’ on cancer: ambitions to diagnose cancers earlier, meet cancer wait targets and improve best practice treatment must happen quickly,” she said, adding that “funding and resources to translate ambition into impact” are essential.
The charity is calling for the wider rollout of effective screening programmes, such as the targeted lung health checks using CT scans for high-risk individuals, which by March 2025 had already diagnosed over 7,000 cancers, mostly at an early stage. It also wants acceleration of innovative tests.
Specific cancers illustrate the scale of the challenge. Prostate cancer, the UK’s most common cancer with 64,000 new cases a year, is projected to see incidence rise to around 85,100 annual cases by 2038-2040. Natalia Norori, head of data and evidence at Prostate Cancer UK, warned that with over a million men projected to be living with the disease by 2040, early detection must be a priority.
Prevention remains a key pillar. The Government highlighted its Tobacco and Vapes Bill, which has passed Parliament and will soon become law. It will create a “smokefree generation” by gradually raising the age of sale for tobacco. Mitchell hailed this as a “historic achievement” that will help end smoking-related cancers.
An NHS spokesperson said early diagnosis in England is at a record high, with staff delivering 30% more cancer checks than in 2021. But they conceded more must be done, stating the National Cancer Plan will “transform services to speed up diagnosis, cut waits and improve care”.
With Cancer Research UK projecting annual diagnoses will exceed half a million by 2040, the data presents a clear imperative: record-level demand requires a sustained, well-resourced response to match.